Literature DB >> 8860421

Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain.

L K Fung1, M Shin, B Tyler, H Brem, W M Saltzman.   

Abstract

PURPOSE: The distribution of [(3)H]BCNU following release from polymer implants in the rat brain was measured and evaluated by using mathematical models.
METHODS: [(3)H]BCNU was loaded into p(CPP:SA) pellets, which were subsequently implanted intracerebrally in rats; [(3)H]BCNU was also directly injected into the brains of normal rats and rats with intracranially transplanted 9L gliomas. Concentrations of [(3)H]BCNU on coronal sections of the brain were measured by autoradiography and image processing. For comparison, the kinetics of [(3)H]BCNU release from the p(CPP:SA) polymer discs into phosphate-buffered saline were also measured.
RESULTS: High concentrations of BCNU (corresponding to 1 mM) were measured near the polymer for the entire 30-day experiment. The penetration distance, defined as the distance from the polymer surface to the point where the concentration of [(3)H]BCNU in the tissue had dropped to 10 percent of the maximum value, was determined: penetration distance was 5 mm at day 1 and 1 mm at days 3 through 14. Local concentration profiles were compared with a mathematical model for estimation of the modulus phi (2), an indicator of the relative rate of elimination to diffusion in the brain. From day 3 to 14, phi(2) was 7, indicating that BCNU elimination was rapid compared to the rate of diffusive penetration into tissue. The enhanced penetration observed on day 1 appears to be due to convection of extracellular fluid caused by transient, vasogenic edema, which disappears by day 3.
CONCLUSIONS: Polymer implants produce very high levels of BCNU in the brain, but BCNU penetration into brain tissue is limited due to rapid elimination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8860421     DOI: 10.1023/a:1016083113123

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia.

Authors:  F M SCHABEL; T P JOHNSTON; G S McCALEB; J A MONTGOMERY; W R LASTER; H E SKIPPER
Journal:  Cancer Res       Date:  1963-06       Impact factor: 12.701

2.  Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.

Authors:  L K Fung; M G Ewend; A Sills; E P Sipos; R Thompson; M Watts; O M Colvin; H Brem; W M Saltzman
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

3.  Biological membranes behave as non-porous polymeric sheets with respect to the diffusion of non-electrolytes.

Authors:  W R Lieb; W D Stein
Journal:  Nature       Date:  1969-10-18       Impact factor: 49.962

Review 4.  Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas.

Authors:  A Olivi; H Brem
Journal:  Recent Results Cancer Res       Date:  1994

5.  Functional and chemical markers of PCNU activity.

Authors:  P M Kanter; H S Schwartz; C R West
Journal:  Cancer Drug Deliv       Date:  1983

Review 6.  Vascular and interstitial barriers to delivery of therapeutic agents in tumors.

Authors:  R K Jain
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

7.  Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier.

Authors:  P A Grabb; M R Gilbert
Journal:  J Neurosurg       Date:  1995-06       Impact factor: 5.115

8.  Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

Authors:  R J Tamargo; J S Myseros; J I Epstein; M B Yang; M Chasin; H Brem
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

9.  Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.

Authors:  H Brem; R J Tamargo; A Olivi; M Pinn; J D Weingart; M Wharam; J I Epstein
Journal:  J Neurosurg       Date:  1994-02       Impact factor: 5.115

10.  In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.

Authors:  M P Wu; J A Tamada; H Brem; R Langer
Journal:  J Biomed Mater Res       Date:  1994-03
View more
  67 in total

Review 1.  Camptothecin delivery methods.

Authors:  A Hatefi; B Amsden
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Ultrasound-enhanced drug transport and distribution in the brain.

Authors:  Ying Liu; Sumit Paliwal; Krystof S Bankiewicz; John R Bringas; Gill Heart; Samir Mitragotri; Mark R Prausnitz
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

Review 3.  Novel delivery strategies for glioblastoma.

Authors:  Jiangbing Zhou; Kofi-Buaku Atsina; Benjamin T Himes; Garth W Strohbehn; W Mark Saltzman
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

4.  Current status of intratumoral therapy for glioblastoma.

Authors:  Ankit I Mehta; Andreas Linninger; Maciej S Lesniak; Herbert H Engelhard
Journal:  J Neurooncol       Date:  2015-08-02       Impact factor: 4.130

5.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

Review 6.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

7.  A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients.

Authors:  Edward Pan; Susan B Mitchell; Jerry S Tsai
Journal:  J Neurooncol       Date:  2008-04-04       Impact factor: 4.130

Review 8.  Controlled release for local delivery of drugs: barriers and models.

Authors:  Jennifer R Weiser; W Mark Saltzman
Journal:  J Control Release       Date:  2014-05-04       Impact factor: 9.776

Review 9.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Authors:  Muna Aryal; Costas D Arvanitis; Phillip M Alexander; Nathan McDannold
Journal:  Adv Drug Deliv Rev       Date:  2014-01-22       Impact factor: 15.470

Review 10.  Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.

Authors:  Jinbing Xie; Zheyu Shen; Yasutaka Anraku; Kazunori Kataoka; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2019-09-14       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.